Vincent Ippolito
Président chez BOTANIX PHARMACEUTICALS LIMITED
Fortune : 2 M $ au 30/06/2024
Postes actifs de Vincent Ippolito
Sociétés | Poste | Début | Fin |
---|---|---|---|
BOTANIX PHARMACEUTICALS LIMITED | Président | 18/07/2019 | - |
President | 20/05/2019 | - | |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 28/08/2017 | - |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA. | Président | 01/07/2019 | - |
President | 20/05/2019 | - |
Historique de carrière de Vincent Ippolito
Anciens postes connus de Vincent Ippolito
Sociétés | Poste | Début | Fin |
---|---|---|---|
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Directeur des opérations | 29/09/2017 | 01/01/2019 |
President | 29/09/2017 | 01/01/2019 | |
ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 10/03/2014 | 30/09/2017 |
MEDICIS PHARMACEUTICAL CORP | Sales & Marketing | 01/01/2003 | 01/03/2014 |
NOVARTIS AG | Sales & Marketing | 02/01/2003 | 02/01/2003 |
BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | 11/12/2012 | - |
Formation de Vincent Ippolito
University of Wisconsin-Eau Claire | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Suisse | 3 |
Australie | 2 |
Opérationnelle
President | 3 |
Sales & Marketing | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 8 |
Consumer Services | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
NOVARTIS AG | Health Technology |
BAUSCH HEALTH COMPANIES INC. | Health Technology |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
Entreprise privées | 5 |
---|---|
Medicis Pharmaceutical Corp.
Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Suneva Medical, Inc.
Suneva Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Suneva Medical, Inc. develops, manufactures and commercializes novel, differentiated aesthetic products for the dermatology, plastic, and cosmetic surgery markets. It offers ArteFill, ReFissa, Bellafill, and ReGenica Skincare products. The company is headquartered in San Diego, CA. | Electronic Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
Botanix Pharmaceuticals, Inc.
Botanix Pharmaceuticals, Inc. BiotechnologyHealth Technology Botanix Pharmaceuticals, Inc. develops therapeutics for the treatment of serious skin diseases. Its products include BTX1503-Acne, BTX1308-Plaque Psoriasis, and BTX1204-Atopic Dermatitis. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
- Bourse
- Insiders
- Vincent Ippolito
- Expérience